Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsMenlo Park, United States
Orca Bio
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
- Founded
- 2016 10 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $250M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
10 years old.
Reach
Website ranked #5,844,617 in the world for traffic, about 1k visits a month.
What it does
Health CareMedicalPharmaceutical
Funding, as listed
$250M currency not stated
- Rounds3
- LatestSeries d, Jun 2020
- Investors12, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Orca Bio, field by field. Contact details are held but never shown.
The company
- Name
- Orca Bio
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Ivan Dimov, Jeroen Bekaert, Nathaniel Fernhoff, Ronald Martell
- Industry
- pharmaceuticals
- Categories
- Health Care, Medical, Pharmaceutical
Where
- City
- Menlo Park
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #5,844,617
- Monthly web visits
- 1,202
Funding, as listed
- Total
- 250,000,000 (currency not stated)
- Rounds
- 3
- Latest round
- Series d
- Latest round date
- Jun 2020
- Investors
- 12
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Orca Bio may be growing as evidenced by their active participation in significant industry events and the positive clinical outcomes they have reported. The company's presentation at the 42nd Annual J.P. Morgan Healthcare Conference suggests an active engagement with the healthcare investment community, which is often a platform for growing companies to attract investors and partnerships. Additionally, Orca Bio's announcement of positive clinical outcomes with Orca-T in patients with Acute Myeloid Leukemia (AML) at the 2024 ASCO Annual Meeting indicates progress in their clinical programs and potential advancements in their product pipeline. These developments suggest that Orca Bio is making strides in its clinical-stage efforts, which could contribute to its growth trajectory within the healthcare and pharmaceutical industries.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.